Cargando…
CKD: The burden of disease invisible to research funders
The uptake of the current concept of chronic kidney disease (CKD) by the public, physicians and health authorities is low. Physicians still mix up CKD with chronic kidney insufficiency or failure. In a recent manuscript, only 23% of participants in a cohort of persons with CKD had been diagnosed by...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad Española de Nefrología. Published by Elsevier España, S.L.U.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040466/ https://www.ncbi.nlm.nih.gov/pubmed/36153901 http://dx.doi.org/10.1016/j.nefroe.2021.09.005 |
_version_ | 1784694342727761920 |
---|---|
collection | PubMed |
description | The uptake of the current concept of chronic kidney disease (CKD) by the public, physicians and health authorities is low. Physicians still mix up CKD with chronic kidney insufficiency or failure. In a recent manuscript, only 23% of participants in a cohort of persons with CKD had been diagnosed by their physicians as having CKD while 29% has a diagnosis of cancer and 82% had a diagnosis of hypertension. For the wider public and health authorities, CKD evokes kidney replacement therapy (KRT). In Spain, the prevalence of KRT is 0.13%. A prevalent view is that for those in whom kidneys fail, the problem is “solved” by dialysis or kidney transplantation. However, the main burden of CKD is accelerated aging and all-cause and cardiovascular premature death. CKD is the most prevalent risk factor for lethal COVID-19 and the factor that most increases the risk of death in COVID-19, after old age. Moreover, men and women undergoing KRT still have an annual mortality which is 10–100-fold higher than similar age peers, and life expectancy is shortened by around 40 years for young persons on dialysis and by 15 years for young persons with a functioning kidney graft. CKD is expected to become the fifth global cause of death by 2040 and the second cause of death in Spain before the end of the century, a time when 1 in 4 Spaniards will have CKD. However, by 2022, CKD will become the only top-15 global predicted cause of death that is not supported by a dedicated well-funded CIBER network research structure in Spain. Leading Spanish kidney researchers grouped in the kidney collaborative research network REDINREN have now applied for the RICORS call of collaborative research in Spain with the support of the Spanish Society of Nephrology, ALCER and ONT: RICORS2040 aims to prevent the dire predictions for the global 2040 burden of CKD from becoming true. However, only the highest level of research funding through the CIBER will allow to adequately address the issue before it is too late. |
format | Online Article Text |
id | pubmed-9040466 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90404662022-04-26 CKD: The burden of disease invisible to research funders Nefrologia (Engl Ed) Special Article The uptake of the current concept of chronic kidney disease (CKD) by the public, physicians and health authorities is low. Physicians still mix up CKD with chronic kidney insufficiency or failure. In a recent manuscript, only 23% of participants in a cohort of persons with CKD had been diagnosed by their physicians as having CKD while 29% has a diagnosis of cancer and 82% had a diagnosis of hypertension. For the wider public and health authorities, CKD evokes kidney replacement therapy (KRT). In Spain, the prevalence of KRT is 0.13%. A prevalent view is that for those in whom kidneys fail, the problem is “solved” by dialysis or kidney transplantation. However, the main burden of CKD is accelerated aging and all-cause and cardiovascular premature death. CKD is the most prevalent risk factor for lethal COVID-19 and the factor that most increases the risk of death in COVID-19, after old age. Moreover, men and women undergoing KRT still have an annual mortality which is 10–100-fold higher than similar age peers, and life expectancy is shortened by around 40 years for young persons on dialysis and by 15 years for young persons with a functioning kidney graft. CKD is expected to become the fifth global cause of death by 2040 and the second cause of death in Spain before the end of the century, a time when 1 in 4 Spaniards will have CKD. However, by 2022, CKD will become the only top-15 global predicted cause of death that is not supported by a dedicated well-funded CIBER network research structure in Spain. Leading Spanish kidney researchers grouped in the kidney collaborative research network REDINREN have now applied for the RICORS call of collaborative research in Spain with the support of the Spanish Society of Nephrology, ALCER and ONT: RICORS2040 aims to prevent the dire predictions for the global 2040 burden of CKD from becoming true. However, only the highest level of research funding through the CIBER will allow to adequately address the issue before it is too late. Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. 2022 2022-04-26 /pmc/articles/PMC9040466/ /pubmed/36153901 http://dx.doi.org/10.1016/j.nefroe.2021.09.005 Text en © 2021 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Special Article CKD: The burden of disease invisible to research funders |
title | CKD: The burden of disease invisible to research funders |
title_full | CKD: The burden of disease invisible to research funders |
title_fullStr | CKD: The burden of disease invisible to research funders |
title_full_unstemmed | CKD: The burden of disease invisible to research funders |
title_short | CKD: The burden of disease invisible to research funders |
title_sort | ckd: the burden of disease invisible to research funders |
topic | Special Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040466/ https://www.ncbi.nlm.nih.gov/pubmed/36153901 http://dx.doi.org/10.1016/j.nefroe.2021.09.005 |
work_keys_str_mv | AT ckdtheburdenofdiseaseinvisibletoresearchfunders AT ckdtheburdenofdiseaseinvisibletoresearchfunders AT ckdtheburdenofdiseaseinvisibletoresearchfunders AT ckdtheburdenofdiseaseinvisibletoresearchfunders AT ckdtheburdenofdiseaseinvisibletoresearchfunders AT ckdtheburdenofdiseaseinvisibletoresearchfunders AT ckdtheburdenofdiseaseinvisibletoresearchfunders AT ckdtheburdenofdiseaseinvisibletoresearchfunders AT ckdtheburdenofdiseaseinvisibletoresearchfunders |